Pharmacologic Actions: News and Research on Complement Inactivating Agents

Researchers establish optimal immunosuppression regimen for pig-to-human kidney transplants

Currently used Food and Drug Administration-approved transplant drugs—with the addition of an also already FDA-approved complement inhibitor—are the optimal immunosuppression regimen for pig-to-human kidney transplants, according ...